Ukrainian communities across the United States are sending essential medical and humanitarian supplies to Ukraine via organizations, including the Ukrainian Medical Association of North America, said Solomiya Grushchak, a member of UMANA.
Changes at Mission Control notwithstanding, the new Cancer Moonshot is ready for liftoff, says Danielle Carnival, coordinator of the White House cancer initiative.
The COVID-19 pandemic disrupted cancer screening and treatment and exacerbated health disparities, but also created unexpected opportunities in cancer research and care, a recent report from the American Association for Cancer Research states.
Raymond N. DuBois has joined The Mark Foundation for Cancer Research as executive chairman of the board.
Edith Mitchell came a long way from growing up on a Tennessee farm, to becoming a brigadier general and serving on the President’s Cancer Panel.
Harold Freeman had big plans after he finished his residency at Memorial Sloan Kettering Cancer Center in 1968. He planned to cut cancer out of Harlem.
FDA is preparing to review an estimated 25 applications for cancer drugs that are being developed based largely—and in many cases entirely—on data from mainland China.
The Cancer History Project Guest Editor Robert Winn focused on the legacy of LaSalle Leffall, a Howard University surgical oncologist. He and John H. Stewart, director of Louisiana State University-Louisiana Children’s Medical Center Health Cancer Center spoke with Wayne A.I. Frederick, president of Howard University.
St. Jude Children’s Research Hospital’s new $200-million Global Platform for Access to Childhood Cancer Medicines—a partnership with the World Health Organization—can be traced back to a critique from a visiting reviewer.
Many global health professionals have dreamed about solving drug shortages, and St. Jude Children’s Research Hospital is taking the first steps toward eliminating the problem, said Carlos Rodriguez-Galindo, director of St. Jude Global.
